Latest News

Date Title Topic
31 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for a Fixed Dose Combination Netupitant/Palonosetron Palliative and supportive care
30 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Lenvatinib Endocrine cancers - Anticancer agents & Biologic therapy
27 Mar 2015 ESMO Press Release: Clinical Trial Design in the Era of Targeted Therapies Translational research
25 Mar 2015 New Insights Into Survival Outcomes of Asian Americans Diagnosed with Cancer Epidemiology/Etiology/Cancer Prevention
25 Mar 2015 EMA's Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Osteonecrosis of the Jaw with Bisphosphonate Medicine Palliative and supportive care
Programme
Webcasts
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy
10 Mar 2015 FDA Approves First Biosimilar Product in the USA Palliative and supportive care
09 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Pegfilgrastim (Ristempa) Palliative and supportive care
06 Mar 2015 ESMO South-East Asia Summit: Meeting Resources
06 Mar 2015 FDA Expands Approved Use of Nivolumab to Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
03 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy